Skip to content

The Efficacy and the Safety of Dexmedetomidine Sedation on the Pediatric Intensive Unit(PICU) Patients.

The Efficacy and the Safety of Dexmedetomidine Sedation on the PICU Patients-A Randomized, Controlled Study.

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02296073
Enrollment
120
Registered
2014-11-20
Start date
2014-12-31
Completion date
2015-12-31
Last updated
2014-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Failed Conscious Sedation During Procedure

Keywords

Pediatric intensive care unit, Sedation, Dexmedetomidine, mechanical ventilation

Brief summary

To observe the efficacy and safety of dexmedetomidine sedation on the patients admitted to the pediatric intensive care unit after surgery.

Interventions

DRUGMidazolam

midazolam 3~5μg/kg•min for maintenance of sedation.

DRUGDexmedetomidine

Dexmedetomidine 0.5μg/kg intravenous bump for 15 min,then 0.2~1.4μg/(kg.h) for maintenance of sedation;

DRUGFentanyl

Fentanyl 0.5~4 μg/(kg.h) for maintenance of analgesia

OTHERassessment

Ramsay score for sedation assessment, Facial expression, leg movement, activity, cry, and consolability score (FLACC) for analgesia assessment.

Sponsors

Anhui Provincial Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Months to 16 Years
Healthy volunteers
No

Inclusion criteria

1. written informed consent; 2. pediatric patients admitted to intensive care unit after general anesthesia; 3. expected mechanical ventilation time \>6 hours; (4)1 months to 16 years old; -

Exclusion criteria

1. congenital heart disease, arrhythmias and heart failure; 2. Alanine transaminase(ALT) and (or) Aspartate aminotransferase(AST) level is more than twice the upper limit of normal; 3. Creatinine and (or) Blood urea nitrogen(BUN) is more than the upper limit of normal; 4. central nervous system disease; 5. spinal analgesia or muscle relaxants is used during PICU; 6. the drug that affects the nerve conduction is used in one month; 7. allergy to the test drug or having other contraindications; 8. participated in other studies 30 days prior to admission of PICU; -

Design outcomes

Primary

MeasureTime frameDescription
percentage of time at target sedation scoreup to 24 hoursassess the sedation level every 2 min using Ramsay score
the number of patients requiring the sedation remedyup to 24 hoursthe number of patients requiring the sedation remedy during the mechanical ventilation
the dosage of midazolam that need for the sedation remedyup to 24 hoursthe dosage of midazolam that need for sedation remedy during the mechanical ventilation

Secondary

MeasureTime frameDescription
change of blood pressureup to 24 hours.the change of blood pressure at 1 min、10 min、20 min、30 min、1 hours、2 hours、3 hours、4 hours、5 hours、6 hours、12 hours、18 hours、24 hours after the sedation drug used.
change of heart rateup to 24 hoursthe change of heart rate at 1 min、10 min、20 min、30 min、1 hours、2 hours、3 hours、4 hours、5 hours、6 hours、12 hours、18 hours、24 hours after the sedation drug used.
change of respiratory rateup to 24 hoursthe change of respiratory rate at 1 min、10 min、20 min、30 min、1 hours、2 hours、3 hours、4 hours、5 hours、6 hours、12 hours、18 hours、24 hours after the sedation drug used.
change of blood oxygen saturationup to 24 hoursthe change of blood oxygen saturation at 1 min、10 min、20 min、30 min、1 hours、2 hours、3 hours、4 hours、5 hours、6 hours、12 hours、18 hours、24 hours after the sedation drug used.
extubation timeup to 24 hourstime from beginning of study drug used to extubation
change of hepatic functionup to 24 hourschange of blood ALT、AST level at baseline and 24 hours after the sedation drug used.
change of renal functionup to 24 hourschange of blood Cr、BUN level at baseline and 24 hours after the sedation drug used.
the dosage of sedation and analgesia drugup to 24 hoursthe total dosage of sedation and analgesia drug during the sedation and analgesia period
the number of patients requiring fentanyl analgesia in and after 6 hours from study drug usedup to 24 hours
the dosage of fentanyl in and after 6 hours from study drug usedup to 24 hours

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026